January 13, 2026

Treat H. pylori Early to Prevent Cancer

Current pediatric guidance is cautious.

Conexiant

January 08, 2026

Non–Total Body Irradiation Conditioning Regimen for Young Patients With MRD-Negative B-ALL

Using a chemotherapy-based conditioning regimen led to 2-year event-free survival rates comparable to that of total body irradiation–based conditioning regimens in pediatric and young adult patients w...

The ASCO Post

December 22, 2025

Eliminating Barriers to Care for Patients With Intellectual and/or Developmental Disabilities

A recent large, retrospective study by Giblon et al has found that individuals with intellectual and/or developmental disabilities face an increased risk of developing cancer, higher symptom burden on...

The ASCO Post

December 17, 2025

Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants

Dana-Farber Cancer Institute’s adult stem cell transplant program and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center’s pediatric stem cell transplant program have once again received exceptional ratings from the Center for International Blood & Marrow Transplant Research (CIBMTR), earning a +1 performance score, the highest possible designation, on their annual center-specific survival reports.

Dana-Farber

December 17, 2025

Promising Data For Off-the-Shelf Gene-edited Cell Therapy

New clinical results outline patient responses to a donor-derived, gene-edited cell therapy in relapsed and refractory T-cell leukemia

The Medicine Maker

December 04, 2025

Dana-Farber researchers present findings at 2025 San Antonio Breast Cancer Symposium

Physician scientists from Dana-Farber Cancer Institute will present more than 50 research studies at the 48th annual San Antonio Breast Cancer Symposium, December 9-12.

Dana-Farber

January 25, 2024

George D. Demetri, MD, FASCO, Earns Lifetime Achievement Award in Medicine From Stanford Medicine Alumni Association

George D. Demetri, MD, FASCO, Director of the Sarcoma Center at Dana-Farber Cancer Institute, was awarded the J.E. Wallace Sterling Lifetime Achievement Award in Medicine from the Stanford Medicine Al...

The ASCO Post

December 01, 2023

Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors

Is the risk of subsequent colorectal cancer elevated among childhood cancer survivors who had undergone, specifically, abdominopelvic radiotherapy? A European study investigated.

The ASCO Post

October 23, 2024

Risk of Subsequent Neoplasms in Survivors of Childhood Neuroblastoma

In a Dutch study reported in the Journal of Clinical Oncology, Westerveld et al identified long-term risks of subsequent neoplasms in 5-year survivors of childhood neuroblastoma.

The ASCO Post